July 10, 2020

July 10, 2020

Suncoast Science & Blood Centers Partner to Increase Blood Donations Amid COVID-19

Suncoast Post – July 9

SunCoast also partners with Moffitt Cancer Center to provide blood products including pathogen reduced platelets. 

 

Ground Broken for Moffitt Cancer Center Surgical Hospital

Medical Construction and Design – July 9

A groundbreaking ceremony was recently held for a new Moffitt Cancer Center project in Tampa, Florida.

 

Oncologie Expands and Strengthens Management Team with Key Appointments and Promotions

Globe Newswire – July 9

This could improve clinical outcomes by matching patients to therapies with a mechanism of action that targets that specific biology and expand precision medicine to those therapies whose potential remains unrealized. Oncologie is further optimizing the biomarker platform’s tumor microenvironment panel through multiple research collaborations, including a collaboration with Moffitt Cancer Center.  

 

Moffitt researchers identify protein that causes epithelial cancers to spread

MLO Online – July 9

In a new article published in the July issue of Cancer Research, researchers at Moffitt Cancer Center in Tampa, FL, discovered a key protein that oscillates its expression through microRNA regulation to facilitate cancer spread to distant organs.

 

TG Therapeutics Announces Publication in Blood Advances Describing Unique Immunomodulatory Effects on CLL T cells by Umbralisib

Globe Newswire – July 8

Javier Pinilla-Ibarz, Lymphoma Section Head, Director of Immunotherapy, Malignant Hematology Division at the H. Lee Moffitt Cancer Center in Tampa, Florida, and the senior author on the publication stated, “We have long been intrigued by the unique properties umbralisib has exhibited as a PI3K inhibitor. It is evident from the non-clinical work published today and from the clinical data seen thus far, that umbralisib is a novel molecule with differentiated effects on the T cell repertoire. We are pleased to contribute to elucidating the mechanisms of umbralisib and look forward to continuing our research.”

 

Aspirus Keweenaw Adds Providers

Keweenaw Report – July 8

Dr. Khaira also was an Assistant Professor and Bone Marrow Transplant hospitalist at Moffitt Cancer Center in Tampa, Florida, and University of Washington in Seattle.

 

Retreatment with CAR-T therapy shows clinical efficacy in lymphoma

Healio – July 8

“While [axicabtagene ciloleucel] has demonstrated durable responses in a subset of patients, approximately half of all responders relapse and little is known about the efficacy of retreatment with CAR T-cell therapy,” Frederick L. Locke, MD, co-leader of the Immunology Program at Moffitt Cancer Center in Tampla, Florida, said in his recorded presentation.

 

American Cancer Society recommends routine HPV vaccination starting at age 9 years

Healio -  July 8 

I do not agree with the American Cancer Society position on HPV vaccination for those aged older than 26 years — which is contrary to CDC guidelines for this age group — to not even discuss the opportunity with their providers. - Anna R. Giuliano, PhD., Moffitt Cancer Center

 

One Liners Hillsborough: Sprouts, Outback Bowl and more

Tampa Bay Business and Wealth – July 8

Moffitt Cancer Center promoted John Cleveland to center director.

 

Radiomics Can Identify High-Risk Early Stage Lung Cancer

Medscape – July 7

"We view radiomics as a decision support tool across the cancer control continuum, whether it be screening and early detection, diagnosis, prognostication, or treatment response," said lead author Matthew B. Schabath, PhD, associate member in cancer epidemiology at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida. This article was also posted on MDEdge.

 

HER2+ Breast Cancer With Brain Metastases: Unmet Needs Remain

Oncology Nursing News – July 7

In an interview with Oncology Nursing News' sister publication, OncLive during the Institutional Perspectives in Cancer on Breast Cancer, Czerniecki, chair and senior member of Department of Breast Oncology at Moffitt Cancer Center, further discussed the unmet needs of patients with HER2-positive breast cancer who have CNS metastases and intriguing research efforts in the pipeline. You can read the Onclive version here.

 

Novel treatment for mesothelioma shows promise for patients

New Kerala – July 6

MPM is a devastating cancer of the membranes surrounding the lungs and it is very difficult to treat, said Bela Kis, MD, PhD, the principal investigator on the study and an interventional radiologist at the Moffitt Cancer Center in Tampa. 

 

Disrupt the Bay targets pediatric cancers, childhood diseases, COVID-19

83 Degrees – July 7

Conference speakers include John Nosta, President of NostaLab, a healthcare “innovation think tank,” Scott Arnold, Executive VP and CIO at Tampa General Hospital, and panelists from Johns Hopkins All Children’s Hospital, Moffitt Cancer Center, Advent Health, Baycare Health, HCA Healthcare, Memorial Healthcare, and Jackson Health.

 

Other news to note

BioWorld – July 6

Anixa Biosciences Inc., of San Jose, Calif., is shifting its business focus to develop therapeutics and vaccines for high-need patient populations, including a cancer immunotherapy program with the Moffitt Cancer Center using chimeric endocrine receptor T-cell technology. 

 

Moffitt researchers discover key protein involved in cancer metastasis

NewsWise Medical – July 6

Moffitt Cancer Center researchers are working to better understand what happens at the cellular level of cancer to develop new strategies to prevent and treat metastasis. In a new article published in the July issue of Cancer Research, Elsa Flores, Ph.D., and her team discovered a key protein that oscillates its expression through microRNA regulation to facilitate cancer spread to distant organs.

 

Epilogue: Long-time Brandon High agriculture teacher, fair entertainer, honorary mayor dies at 94

Tampa Bay Times – July 4

Valerie Storms is a chaplain at the Moffitt Cancer Center in Tampa. She’s also the only female ordained minister of the First Baptist Church in Brandon, she said, something her father was proud of.

 

Cancer Concerns During COVID

Daytime/WFLA – July 3

Moffitt Cancer Center is one of the safest places you can go. Dr. Bethany Niell is section chief of breast imaging at Moffitt and she joins us now.

 

Dr. Kim on Efficacy and Next Steps With Regorafenib/Nivolumab Combo in CRC

OncLive – July 3

Richard D. Kim, MD, a medical oncologist within the Department of Gastrointestinal Oncology at Moffitt Cancer Center and an assistant professor of oncology with University of South Florida College of Medicine, discusses the efficacy of and next steps for a phase 1/1b study with regorafenib (Stivarga) and nivolumab (Opdivo) in patients with mismatch repair proficient advanced refractory colorectal cancer (CRC).

 

How Does Cardiotoxicity Present Itself in Patients With Cancer?

Let Life Happen – July 4

“And lastly, we would like to outline a multidisciplinary approach between cardiologists and oncologists to manage cardio-oncology patients using recommendations and optimizing survivorship outcomes,” noted Roohi Ismail-Khan, MD, MSc, medical oncologist and co-director of the cardio-oncology program H. Lee Moffitt Cancer Center.

 

‘Alarming' CRC Hotspots; A Pandemic Opportunity; Microbubble Cancer Therapy?

MedPage Today – July 2

Incorporating radiomics in lung cancer screening may help identify early-stage patients at risk of poor outcomes. (Moffitt Cancer Center, Nature Scientific Reports)

 

Moffitt develops tool to detect patients at high risk for poor lung cancer outcomes

DotMed – July 2

However, low dose CT does have its limitations, such as over diagnosing slow-growing lung cancers that may never cause detriment to the patient. In a new study published in Nature Scientific Reports, Moffitt Cancer Center researchers have shown how the use of radiomics can improve lung cancer screening by identifying early stage lung cancer patients who may be at high risk for poorer outcomes, and therefore require aggressive follow-up and/or adjuvant therapy. Also posted to Medical Xpress and Newswise.

 

Tampa Commercial Real Estate Wrap-Up – June 2020

Commercial Property Executive – June 2020

Moffitt Cancer Center starts $400 million expansion.

 

Global Small Molecule Cancer Drug Market to 2026 - Drug Price, Dosage & Clinical Trials Insight - ResearchAndMarkets.com
Digital Journal – July 2
Aptose Biosciences & Moffitt Cancer Center to Undergo Strategic Collaboration for the Development of New Multi-Targeting Epigenetic Therapeutic Agents

 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.